4//SEC Filing
Patel Gautam 4
Accession 0001628280-25-000581
CIK 0001723128other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:22 PM ET
Size
5.2 KB
Accession
0001628280-25-000581
Insider Transaction Report
Form 4
Patel Gautam
Director
Transactions
- Sale
Class A Common Stock
2025-01-02$8.01/sh−17,410$139,454→ 2,031,476 total
Footnotes (1)
- [F1]These transactions occurred automatically pursuant to a plan adopted by the Reports Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.06 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001738054
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:22 PM ET
- Size
- 5.2 KB